Claim: A rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling the vaccine off the market globally, citing a decline in demand. Social media posts misleadingly linked the decision to the company having "admitted" the rare side effect "for the first time" in court documents and used it to impugn all vaccines.
Fact-check: Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
Verdict: a rare risk of dangerous blood clots associated with the astrazeneca covid-19 vaccine was identified and reported in early 2021. this month, the company announced it was pulling the vaccine off the market globally, citing a decline in demand. social media posts misleadingly linked the decision to the company having "admitted" the rare side effect "for the first time" in court documents and used it to impugn all vaccines.
Organisation: FactCheck.org
Author: Catalina Jaramillo
Date published: 2024-05-23T19:16:27